Inspire Medical Systems Inc (INSP)

The Inspire system works by stimulating airway muscles during sleep to help keep the airway open. The therapy is implanted through a minimally invasive surgical procedure and is controlled by the patient with an external remote. This approach differentiates Inspire from mask-based therapies and positions the company in a specialised segment of the sleep medicine and ear, nose and throat markets.

Inspire generates revenue from sales of its system to hospitals and ambulatory surgery centres. The United States is its largest market, while the company also sells in selected international markets, including parts of Europe and the Asia-Pacific region. Its commercial model depends on physician training, patient awareness, reimbursement coverage, surgical capacity and clinical evidence supporting long-term outcomes.

As a growth-oriented medtech company, Inspire is tied to adoption rates among sleep specialists and surgeons, the size of the eligible patient population and the broader healthcare reimbursement environment. Its distinctive role is the commercialisation of a neurostimulation-based alternative for obstructive sleep apnea, addressing a patient group that often struggles with adherence to conventional treatment.